share_log

PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Abbe(7.0%),Iroquois Master Fund Ltd.(6.6%), etc.

PharmaCyte Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Richard Abbe(7.0%),Iroquois Master Fund Ltd.(6.6%)等

美股SEC公告 ·  2023/05/12 16:22
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息